{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:35:08Z","timestamp":1783488908599,"version":"3.55.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1093\/humrep\/dey236","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T15:10:19Z","timestamp":1528816219000},"page":"1499-1505","source":"Crossref","is-referenced-by-count":21,"title":["Performance of prognostic modelling of high and low ovarian response to ovarian stimulation for IVF"],"prefix":"10.1093","volume":"33","author":[{"given":"Markus O","family":"Scheinhardt","sequence":"first","affiliation":[{"name":"Institute of Medical Biometry and Statistics, University of Luebeck, Ratzeburger Allee 160, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Lerman","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine and Gynecological Endocrinology, University Hospital of Schleswig-Holstein, Campus Luebeck, Ratzeburger Allee 160, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inke R","family":"K\u00f6nig","sequence":"additional","affiliation":[{"name":"Institute of Medical Biometry and Statistics, University of Luebeck, Ratzeburger Allee 160, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0606-5804","authenticated-orcid":false,"given":"Georg","family":"Griesinger","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine and Gynecological Endocrinology, University Hospital of Schleswig-Holstein, Campus Luebeck, Ratzeburger Allee 160, Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,10]]},"reference":[{"key":"key\n\t\t\t\t20180731122958_dey236C1","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/humrep\/der318","article-title":"Xpect investigators. Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment","volume":"26","author":"Andersen","year":"2011","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180731122958_dey236C2","first-page":"20","article-title":"mfp: multivariable fractional polynomials","volume":"5","author":"Benner","year":"2005","journal-title":"R News"},{"key":"key\n\t\t\t\t20180731122958_dey236C3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fertnstert.2015.04.018","article-title":"Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization","volume":"104","author":"Boostanfar","year":"2015","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180731122958_dey236C4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20180731122958_dey236C5","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/humrep\/deu090","article-title":"Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol","volume":"29","author":"Broekmans","year":"2014","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180731122958_dey236C6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180731122958_dey236C7","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/humrep\/den288","article-title":"A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation","volume":"23","author":"Corifollitropin Alfa Dose-finding Study Group","year":"2008","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180731122958_dey236C8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rbmo.2010.03.019","article-title":"Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women","volume":"21","author":"Corifollitropin Alfa Ensure Study Group","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20180731122958_dey236C9","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180731122958_dey236C10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/humupd\/dmn065","article-title":"Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency","volume":"15","author":"Fauser","year":"2009","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20180731122958_dey236C11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rbmo.2016.04.005","article-title":"Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis","volume":"33","author":"Griesinger","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20180731122958_dey236C12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/biomet\/76.2.297","article-title":"Regression and time series model selection in small samples","volume":"76","author":"Hurvich","year":"1989","journal-title":"Biometrika"},{"key":"key\n\t\t\t\t20180731122958_dey236C13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/GCO.0000000000000175","article-title":"Ovarian response biomarkers: physiology and performance","volume":"27","author":"Iliodromiti","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key\n\t\t\t\t20180731122958_dey236C14","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/humrep\/dex219","article-title":"Non-equivalence of anti-M\u00fcllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing","volume":"32","author":"Iliodromiti","year":"2017","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180731122958_dey236C15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rbmo.2011.04.002","article-title":"Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response","volume":"23","author":"Ledger","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20180731122958_dey236C16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.rbmo.2017.02.012","article-title":"Ovarian response to 150 \u03bcg corifollitropin alfa in a GnRH-antagonist multiple-dose protocol: a prospective cohort study","volume":"34","author":"Lerman","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"key\n\t\t\t\t20180731122958_dey236C17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2015.06.024","article-title":"Two new automated, compared with two enzyme-linked immunosorbent, antimullerian hormone assays","volume":"104","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180731122958_dey236C18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-M\u00fcllerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180731122958_dey236C19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12958-015-0113-1","article-title":"Predictive factors for ovarian response in a corifollitropin alfa\/GnRH antagonist protocol for controlled ovarian stimulation in IVF\/ICSI cycles","volume":"13","author":"Oehninger","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"key\n\t\t\t\t20180731122958_dey236C20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.fertnstert.2013.04.029","article-title":"Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization\/intracytoplasmic sperm injection","volume":"100","author":"Polyzos","year":"2013","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180731122958_dey236C21","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2018"},{"key":"key\n\t\t\t\t20180731122958_dey236C22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2307\/2986270","article-title":"Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling","volume":"43","author":"Royston","year":"1994","journal-title":"Appl Stat"},{"key":"key\n\t\t\t\t20180731122958_dey236C23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/humupd\/dmq041","article-title":"Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis","volume":"17","author":"Sterrenburg","year":"2011","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20180731122958_dey236C24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/03610927808827599","article-title":"Further analysts of the data by akaike\u2019s information criterion and the finite corrections: further analysts of the data by akaike\u2019s","volume":"7","author":"Sugiura","year":"1978","journal-title":"Commun Stat Theory Methods"},{"key":"key\n\t\t\t\t20180731122958_dey236C25","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/humrep\/dev127","article-title":"Performance of the two new fully automated anti-Mullerian hormone immunoassays compared with the clinical standard assay","volume":"30","author":"van Helden","year":"2015","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/33\/8\/1499\/25365935\/dey236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T06:50:53Z","timestamp":1571467853000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/33\/8\/1499\/5051669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,10]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,7,10]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dey236","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,7,10]]}}}